Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ergometrine maleate plus oxytocin for prevention of postpartum hemorrhage
ChiCTR1800018488Phase 4Not yet recruiting
- Sponsor
- West China Second University Hospital
- Start
- Oct 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ergonovine maleate and oxytocin in postpartum hemorrhage (PPH) (4 arms), sponsored by West China Second University Hospital. Primary endpoint: Blood loss. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
ergonovine maleateoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ChiCTR1800018488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018488.